Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Oxford Biomedica
Biological Product (except Diagnostic) ManufacturingUnited Kingdom
Last verified 4 months agooxb.com
Oxford Biomedica, a leading player in the biological product manufacturing sector, is headquartered in the United Kingdom. Founded in 1995, the company has established itself as a pioneer in gene and cell therapy, focusing on the development and production of advanced therapeutics. With a strong operational presence in Europe and North America, Oxford Biomedica is renowned for its innovative LentiVector® platform, which enables the creation of unique gene therapies.
The company has achieved significant milestones, including partnerships with major pharmaceutical firms and successful clinical trials that underscore its market position. Oxford Biomedica's commitment to quality and innovation in the biomanufacturing landscape has solidified its reputation as a trusted provider of cutting-edge biological products, making it a key contributor to the advancement of modern medicine.
74
DitchCarbon score
+24 vs industry average
Oxford Biomedica’s score of 74 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Oxford Biomedica?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Biological Product (except Diagnostic) Manufacturing has below-average carbon intensity
Industry performance
0.187
20182025
The Biological Product (except Diagnostic) Manufacturing industry has reduced its overall emissions by 22% since 2018
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Oxford Biomedica's reported carbon emissions
Oxford Biomedica, a UK-based Biological Product (except Diagnostic) Manufacturing company, reported its total carbon emissions for 2025 as approximately 66,272,000 kg CO2e. This figure includes Scope 1 emissions of around 2,425,000 kg CO2e, Scope 2 emissions (market-based) of about 1,337,000 kg CO2e, and Scope 3 emissions of approximately 62,510,000 kg CO2e.
Looking back, the company's total emissions were approximately 83,941,000 kg CO2e in 2024 and about 57,595,000 kg CO2e in 2023.
Oxford Biomedica has set near-term Science Based Targets initiative (SBTi) validated targets. The company commits to reducing absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, from a 2021 base year. They also aim to increase active annual sourcing of renewable electricity from 29.1% in 2021 to 100% by 2030. Additionally, Oxford Biomedica commits that 90% of its suppliers by emissions covering purchased goods and services will have science-based targets by 2029.
The company's latest reporting indicates progress towards its targets, having achieved a cumulative reduction of nearly 40% in direct operational emissions against its 2021 baseline.
Assessing Oxford Biomedica as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Oxford Biomedica and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Oxford Biomedica’s Climate Goals (2030 & 2050)
2 goals2030
42% reduction in Scope 1
Oxford Biomedica PLC commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year.
At risk42%
2030
42% reduction in Scope 2
Oxford Biomedica PLC commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year.
At risk42%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
9 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
2030 targetSee details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Oxford Biomedica4 months ago
74
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Oxford Biomedica’s sustainability data and climate commitments
In 2025, Oxford Biomedica reported total carbon emissions of approximately 66,272,000 kg CO2e. This represents a decrease from the approximately 83,941,000 kg CO2e recorded in 2024 and an increase from the about 57,595,000 kg CO2e in 2023. The company's emissions trajectory shows fluctuations, with 2025 emissions being lower than 2024 but higher than 2023. Understanding these year-over-year changes is crucial for assessing the effectiveness of their climate strategies within the Biological Product Manufacturing sector.
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more